ETF (UCITS compliant)

L&G Healthcare Breakthrough UCITS ETF

Fund facts

Fund size
Base currency
Listing date
2 Jul 2019
Index ticker
Replication method
Physical - full replication


As at 30 Sep 2019

Fund aim

The L&G Healthcare Breakthrough UCITS ETF (the "ETF") aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”).

  • Long-term allocation

Long-term megatrend that we believe is radically transforming the way we live and work

  • High growth potential

Aims to capture the outsized growth potential of the healthcare technology industry

  • Leveraging industry expertise

An index tracking investment strategy that is supported by a team of healthcare technology experts

ROBO Global® Healthcare Technology and Innovation Index TR

The Index aims to track the performance of a basket of companies that are actively engaged in the healthcare technology value-chain.

The index is comprised of companies which are publicly traded on various stock exchanges around the world that have a distinct portion of their business and revenue derived from the field of healthcare technologies, and the potential to grow within this space through innovation and/or market adoption of their products and/or services. Companies are included in the index receive a "HTEC Score"  comprised of factors representing (1)the levels of revenue the company receives from innovative healthcare technologies, (2) the levels of investment the firm makes in healthcare technologies, (3) the market and technology leadership of the firm within the universe.

A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" ( a measure of how actively its shares are traded on a daily basis). Within the Index, companies are weighted according a modified HTEC-factor weighting scheme. The Index is rebalanced quarterly in March, June, September and December.

Index data

Bloomberg code
Reuters code
Total Return


As at 30 Sep 2019. All data source LGIM unless otherwise stated. Totals may not sum to 100% due to rounding.

The breakdowns below relate to the Index. The ETF’s portfolio may deviate from the below

Sector (%)

Medical Instruments 27.5
Diagnostics 18.1
Genomics 11.3
Lab Process Automation 10.5
Precision Medicine 10.2
Telehealth 6.8
Robotics 5.7
Data Analytics 5.5
Regenerative Medicine 4.4

Currency (%)

USD 84.6
EUR 5.1
CHF 3.7
GBP 1.7
JPY 1.5
HKD 1.4
AUD 1.1
DKK 0.8
Top 10 constituents 15.4
Rest of Index 84.6
No. of constituents in Index 86

Top 10 constituents (%)

Illumina 1.7
Teladoc 1.6
Intuitive Surgical 1.6
Vocera Communications 1.6
Natera 1.5
Integra Lifesciences 1.5
Myriad Genetics 1.5
Thermo Fisher Scientific 1.5
Charles River Laboratories 1.5
Danaher 1.5

Investment Manager

GO ETF Solutions LLP is the investment manager for each of the exchange traded funds (ETFs) issued by Legal & General UCITS ETF Plc and is responsible for the day-to-day investment management decisions for this ETF. The team is highly experienced with respect to all aspects relating to the management of an ETF portfolio, including collateral management, OTC swap trading, adherence to UCITS regulations and counterparty exposure and monitoring.



Price time
16:00 EST (NY)

Further details

Charges and tax

ISA eligible
SIPP eligible
UK Fund Reporting Status

Management / administration

Legal & General UCITS ETF Plc
Custodian and Trustee
BNY Mellon Trust Company (Ireland) Limited
Computershare Investor Services (Ireland) Ltd
Securities regulator
Central Bank of Ireland

Country registration

This share class is registered for sale in the following countries:


Exchange Currency Ticker Listing date ISIN Bloomberg code Reuters code Trading hours (local)
London Stock Exchange GBP DOCG 02/07/2019 IE00BK5BC677 DOCG LN DOCG.L 08:00 - 16:30
London Stock Exchange USD DOCT 02/07/2019 IE00BK5BC677 DOCT LN DOCT.L 08:00 - 16:30
Borsa Italiana EUR DOCT 10/09/2019 IE00BK5BC677 DOCT IM LGDOCT.MI 09:00 - 17:30
Deutsche Börse EUR XMLH 10/09/2019 DE000A2PPAV6 XMLH GY DOCT.DE 09:00 - 17:30

Key risks

The value of an investment and any income taken from it is not guaranteed and can go down as well as up. You may not get back the amount you originally invested.

Past performance is not a guide to the future.

For more information, please refer to the key investor information document.

Important information

Issued by LGIM ETF Managers Limited as management company for this fund. Registered in Ireland No. 454170. Registered Office: 6th Floor, 2 Grand Canal Square, Dublin, 2, Ireland. Authorised and Regulated by the Central Bank of Ireland No. C50537.

GO ETF Solutions LLP has been appointed as the discretionary investment manager for this Fund, it is authorised and regulated by the Financial Conduct Authority No.477266.

We are a member of the Irish Funds Association.

All features described on this website are those current at the time of publication and may be changed in the future. Nothing on this website should be construed as advice and it is therefore not a recommendation to buy or sell securities. If in doubt about the suitability of this product, you should seek professional advice. Copies of the prospectus, key investor information document, annual and semi-annual reports & accounts are available free of charge on request or at

This website is only directed at investors resident in jurisdictions where our funds are registered for sale. It is not an offer or invitation to persons outside of those jurisdictions.

Source and third party data

Source: Unless otherwise indicated all data contained on this website is sourced from Legal & General Investment Management Limited.

Where this document contains third party data ('Third Party Data’), we cannot guarantee the accuracy, completeness or reliability of such Third Party Data and accept no responsibility or liability whatsoever in respect of such Third Party Data

Index disclaimer

The L&G Healthcare Breakthrough UCITS ETF (the “ETF”) is not sponsored, promoted, sold or supported in any other manner by ROBO Global LLC or Solactive AG (the “Index Parties”), nor do the Index Parties offer any express or implicit guarantee or assurance either with regard to the results of using the ROBO Global® Healthcare Technology and Innovation Index (the “Index”) and/or Index trademark or the Index price at any time or in any other respect. The Index is calculated and published by Solactive AG. The Index Parties use their best efforts to ensure that the Index is calculated correctly. Irrespective of their obligations towards the Company, the Index Parties have no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the ETF. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trademark by ROBO Global LLC for the purpose of use in connection with the ETF constitutes a recommendation by the Index Parties to invest capital in the ETF nor does it in any way represent an assurance or opinion of the Index Parties with regard to any investment in the ETF.

LGIM's latest market insights

Access LGIM’s latest thinking across our range of investment themes to help you make more informed investment decisions.

Read our latest thought leadership

Contact us

Contact us for further information on our investment solutions and services.

Get in touch